CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

Autor: Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV

Publikováno v: Pharmacogenomics and Personalized Medicine, Vol Volume 13, Pp 29-37 (2020)

DA Sychev,1 OA Baturina,2 KB Mirzaev,1 E Rytkin,1 DV Ivashchenko,1 DA Andreev,2 KA Ryzhikova,1 EA Grishina,1 PO Bochkov,1 RV Shevchenko1 1Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation, Mosc

Externí odkaz: https://doaj.org/article/4e50092f7043444a9daf746029723111

Cytochrome P450 3A4 activity and genetic variants as predictors of liver failure in patients with obstructive jaundice.

Autor: Lebedev SS; Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation, Moscow, st. Barrikadnaya, 2/1, Russia; Botkin Hospital, Russian Academy of Sciences, Moscow, st. 2nd Botkinsky proezd, 5, Russia., Tavobilov MM; Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation, Moscow, st. Barrikadnaya, 2/1, Russia; Botkin Hospital, Russian Academy of Sciences, Moscow, st. 2nd Botkinsky proezd, 5, Russia., Karpov AA; Botkin Hospital, Russian Academy of Sciences, Moscow, st. 2nd Botkinsky proezd, 5, Russia., Abramov KA; Botkin Hospital, Russian Academy of Sciences, Moscow, st. 2nd Botkinsky proezd, 5, Russia. Electronic address: botkin.abramov@gmail.com., Bochkov PO; Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation, Moscow, st. Barrikadnaya, 2/1, Russia., Shevchenko RV; Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation, Moscow, st. Barrikadnaya, 2/1, Russia., Denisenko NP; Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation, Moscow, st. Barrikadnaya, 2/1, Russia., Shabunin AV; Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation, Moscow, st. Barrikadnaya, 2/1, Russia; Botkin Hospital, Russian Academy of Sciences, Moscow, st. 2nd Botkinsky proezd, 5, Russia., Sychev DA; Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation, Moscow, st. Barrikadnaya, 2/1, Russia.

Publikováno v: Free radical biology & medicine [Free Radic Biol Med] 2023 Nov 01; Vol. 208, pp. 229-235. Date of Electronic Publication: 2023 Aug 12.

Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.

Autor: Sychev DA; Department of Pharmacology, Federal State Budgetary Educational Institution of Higher Professional Education 'Saratov State Medical University named after V.I.Razumovsky' of the Ministry of Healthcare of the Russian Federation., Sokolov AV; Department of Clinical Pharmacology and Therapy named after B.E. Votchal, Rector of Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Reshetko OV; Department of Clinical Pharmacology and Therapy named after B.E. Votchal, Rector of Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Fisenko VP; Department of Pharmacology of the Institute of Biodesign and Modeling of Complex Systems of Science and Technology Park of Biomedicine, Federal State Autonomous Educational Institution of Higher Professional Education 'First Moscow State Medical University named after I.M. Sechenov (Sechenov University)' of the Ministry of Healthcare of the Russian Federation., Sychev IN; Department of Pharmacology, Federal State Budgetary Educational Institution of Higher Professional Education 'Saratov State Medical University named after V.I.Razumovsky' of the Ministry of Healthcare of the Russian Federation., Grishina EA; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Bochkov PO; Department of Personalized Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Shevchenko RV; Department of Personalized Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Abdullaev SP; Department of Molecular Medicine of Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Health of the Russian Federation., Denisenko NP; Department of Personalized Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Ivashchenko DV; Research Laboratory of Genomic Predictors of Adverse Drug Reactions at the Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Sozaeva ZA; Department of Molecular Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation., Kachanova AA; Department of Molecular Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation.

Publikováno v: Pharmacogenetics and genomics [Pharmacogenet Genomics] 2022 Dec 01; Vol. 32 (9), pp. 301-307. Date of Electronic Publication: 2022 Oct 13.

Preclinical Pharmacokinetics of GZK-111, a Dipeptide with Neuroprotective Activity.

Autor: Litvin AA; Laboratory of Pharmacokinetics, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia. litbiopharm@yandex.ru., Kolyvanov GB; Laboratory of Pharmacokinetics, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia., Bochkov PO; Laboratory of Pharmacokinetics, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia., Shevchenko RV; Laboratory of Pharmacokinetics, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia., Podol'ko AL; Laboratory of Pharmacokinetics, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia., Kolyasnikova KN; Laboratory of Pharmacokinetics, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia., Zherdev VP; Laboratory of Pharmacokinetics, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2022 Jan; Vol. 172 (3), pp. 310-313. Date of Electronic Publication: 2022 Jan 10.

Comparative Preclinical Pharmacokinetics and Bioavailability of Antidepressant GSB-106 Tablet Form.

Autor: Kolyvanov GB; Laboratory of Pharmacokinetics, Moscow, Russia. litbiopharm@yandex.ru., Zherdev VP; Laboratory of Pharmacokinetics, Moscow, Russia., Gribakina OG; Laboratory of Pharmacokinetics, Moscow, Russia., Bochkov PO; Laboratory of Pharmacokinetics, Moscow, Russia., Shevchenko RV; Laboratory of Pharmacokinetics, Moscow, Russia., Litvin AA; Laboratory of Pharmacokinetics, Moscow, Russia., Blynskaya EV; Laboratory of Finished Dosage Forms, V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow, Russia., Bueva VV; Laboratory of Finished Dosage Forms, V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow, Russia.

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2019 Sep; Vol. 167 (5), pp. 637-640. Date of Electronic Publication: 2019 Oct 17.